The 24th Annual Meeting of Pacific and Asian Society of Minimally Invasive Spine Surgery (PASMISS 2024) was successfully held in Tianjin

From August 8 to 10, 2024, hosted by the Pacific and Asian Society of Minimally Invasive Spine Surgery (PASMISS), Tianjin Medical Association, and Orthopedic Consumables and Additive Manufacturing Branch of the Chinese Medical Equipment Association, Tianjin The 24th Annual Meeting of the Asia-Pacific Society for Minimally Invasive Spine Surgery (PASMISS 2024), the Academic Conference on Minimally Invasive Spine Surgery of the Orthopedic Spine Branch of the Chinese Medical Education Association, co-organized by Tianjin Municipal Hospital, the First Affiliated Hospital of Sun Yat-sen University and "Chinese Journal of Orthopedics", The 9th Intervertebral Disc Disease and Spinal Endoscopy Symposium, Bone and Joint Minimally Invasive and Digital Intelligent Diagnosis and Treatment Project - Spinal Endoscopy Training Course" was successfully held in Tianjin, the beautiful coast of the Bohai Sea.

PASMISS, established in 2000, is an academic organization focusing on the concepts, technology and development of minimally invasive spine surgery. The organization holds an academic annual meeting every year. The 24th Tianjin PASMISS Annual Meeting was held for the third time in mainland China after the 2012 Xi'an and 2019 Suzhou annual meetings. It reflects the increasingly prominent position and importance of mainland China in the field of minimally invasive spine surgery. Influence.

This event gathered 631 papers from 20 countries and regions, bringing together 116 international colleagues and more than 500 Chinese experts. The conference carefully set up 5 English and 6 Chinese sub-venues, with a total of 157 English speeches and 230 Chinese reports, comprehensively covering cutting-edge technologies and hot topics in the field of minimally invasive spine surgery. The conference site was in good order and had a strong academic atmosphere, which not only promoted the collision of global wisdom, but also perfectly interpreted the organizational norms and high standards of top international conferences.

Dragon Crown Medical Co., Ltd. attaches great importance to this international exchange platform and formed a cross-department delegation to participate in the meeting. It is led by Alissa, the company’s international department manager, and includes the chief product manager, chief engineer of the R&D department and the head of the market strategy department. and other key positions. The delegation aims to showcase the company's latest scientific and technological achievements, expand international cooperation networks, and grasp the development pulse of the global medical industry through this summit.

Founded in 2002, Dragon Crown Medical Co., Ltd. is a hi-tech enterprise integrating R&D, manufacture and sales of medical products. 

From the first beginning, Dragon Crown has always focused on providing MISS overall solutions in spine and joint surgery fields. Based on its strong R & D capability and innovative spirit, Dragon Crown is equipped with more than 100 domestic and international patents, and has created a whole industrial chain layout of design, R & D, production and sales. Cooperating with renowned domestic professionals, we have developed a series of assets in surgical treatment of spinal and joint diseases, including "APLD", "MED" "PELD", "PVP", "PKP" (Balloon-Vertebral Forming Unitized Surgical Instruments), "Vertebral posterior margin processor", "Expandor Retractor Instrument", "Ramote Controlled Injection Manipulator" and "Arthroscope"etc. These advanced and completed product portfolio represents our pioneer advantages in minimally invasive treatment of spinal and joint diseases. Our unique "Minimally invasive culture" is thus characterized in the effective combination of product research and its clinical utilization.